Jump to content

David W. Hein

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Cockwomble22 (talk | contribs) at 18:09, 4 November 2019 (removed Category:University of Michigan alumni; added Category:University of Michigan College of Pharmacy alumni using HotCat). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

David Hein
Born
NationalityUnited States
EducationUniversity of Wisconsin-Eau Claire; University of Michigan
Occupation(s)Professor; Scientist;
Known forEducation; Cancer research
Children3 sons

David W. Hein is an American professor and scientist. He currently is a Distinguished University Scholar at the University of Louisville where he serves as the Peter K. Knoefel Endowed Chair of Pharmacology and Professor & Chair of the Department of Pharmacology & Toxicology.

Life and education

Hein was born in Faith, South Dakota and attended Wisconsin Lutheran High School in Milwaukee, Wisconsin. He completed his undergraduate work at the University of Wisconsin-Eau Claire where he received a B.S. in chemistry. He completed his PhD in pharmacology at the University of Michigan.

Career

Hein began his career at the Morehouse School of Medicine where he chaired the Department of Pharmacology. In 1989 he was appointed as Professor and Chair of the Department of Pharmacology and Toxicology at the University of North Dakota where he became a Chester Fritz Distinguished Professor. In 1997, Hein moved to the University of Louisville where he serves as the Peter K. Knoefel Professor and Chair of the Department of Pharmacology & Toxicology and Distinguished University Scholar. Additionally, he has presented the Astor Visiting Lectureship at the University of Oxford and serves as a visiting professor at the University of Paris. He was elected to the Academy of Pharmacology Educators of the American Society for Pharmacology and Experimental Therapeutics.[1]

Research

Hein's research in molecular epidemiology helps identify people genetically susceptible to developing cancer from environmental and occupational chemicals, which allows for focus on treatment and prevention. Additionally, his research in genomics sheds light on the genetic causes for prescription drug failure. Widely published in scientific journals, Hein has authored more than 200 articles with a h- index of 56. His work has been cited more than 12000 times.[1]

References

  1. ^ a b "David W. Hein". louisville.edu.